The Effect of CPAP on Lung Hyperinflation in Patients With OSA
The Effect of Continuous Positive Airway Pressure Therapy on Lung Hyperinflation in Patients With Obstructive Sleep Apnoea
1 other identifier
observational
50
1 country
1
Brief Summary
Assessment of the lung hyperinflation by bodypletysmography in patients with obstructive sleep apnoea treated with continuous positive airway pressure therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2019
CompletedStudy Start
First participant enrolled
September 5, 2019
CompletedFirst Posted
Study publicly available on registry
September 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2020
CompletedJanuary 13, 2020
January 1, 2020
4 months
September 5, 2019
January 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change of Vital Capacity (VC) (ml)
Percentage change of Vital Capacity after 3 months of CPAP therapy.
3 months
Change of Forced Expiratory Volume in 1 second (FEV1) (ml)
Percentage change of Forced Expiratory Volume in 1 second after 3 months of CPAP therapy.
3 months
Change of Total Lung Capacity (TLC) (ml)
Percentage change of Total Lung Capacity after 3 months of CPAP therapy.
3 months
Change of Residual Volume (RV) (ml)
Percentage change of Residual Volume after 3 months of CPAP therapy.
3 months
Study Arms (1)
Continuous Positive Airway Pressure
Patient treated with continuous positive airway pressure
Interventions
Standard treatment with continuous positive airway pressure
Eligibility Criteria
Patients with obstructive sleep apnoea syndrome indicated for CPAP therapy
You may qualify if:
- Obstructive sleep apnoea syndrome indicated for CPAP therapy (Apnoea- Hypopnoea index ˃ 15)
You may not qualify if:
- \- Bilevel positive airway pressure therapy
- Total lung capacity \< 80% lower limit of normal values
- Obstructive ventilatory disorder
- Change in body weight ˃ 10%
- Change in smoking status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Olomouc
Olomouc, 77900, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milan Sova, MD, Ph.D.
Department of Respiratory Medicine, University Hospital Olomouc
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Head of Sleep Laboratory, Department of Respiratory Medicine
Study Record Dates
First Submitted
September 5, 2019
First Posted
September 10, 2019
Study Start
September 5, 2019
Primary Completion
January 9, 2020
Study Completion
January 9, 2020
Last Updated
January 13, 2020
Record last verified: 2020-01